<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2139
  </number>
  <updateDate>
   2023-01-11T13:48:04Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:04Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-03-23
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 54 (Tuesday, March 23, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. DOGGETT:H.R. 2139.Congress has the power to enact this legislation pursuantto the following:Clause 1 of Section 8 of Article I of the United StatesConstitution.[Page H1621]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-03-24T15:21:53Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-23T15:06:30Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-03-23T16:39:53Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-23T15:06:35Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Medicare Drug Price Negotiation Act
    </title>
    <congress>
     117
    </congress>
    <number>
     908
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-23
     </actionDate>
     <text>
      Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-03-24
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     D000399
    </bioguideId>
    <fullName>
     Rep. Doggett, Lloyd [D-TX-35]
    </fullName>
    <firstName>
     LLOYD
    </firstName>
    <lastName>
     DOGGETT
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     35
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     W000800
    </bioguideId>
    <fullName>
     Rep. Welch, Peter [D-VT-At Large]
    </fullName>
    <firstName>
     Peter
    </firstName>
    <lastName>
     Welch
    </lastName>
    <party>
     D
    </party>
    <state>
     VT
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001224
    </bioguideId>
    <fullName>
     Rep. Bush, Cori [D-MO-1]
    </fullName>
    <firstName>
     Cori
    </firstName>
    <lastName>
     Bush
    </lastName>
    <party>
     D
    </party>
    <state>
     MO
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000389
    </bioguideId>
    <fullName>
     Rep. Khanna, Ro [D-CA-17]
    </fullName>
    <firstName>
     Ro
    </firstName>
    <lastName>
     Khanna
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000607
    </bioguideId>
    <fullName>
     Rep. Pocan, Mark [D-WI-2]
    </fullName>
    <firstName>
     Mark
    </firstName>
    <lastName>
     Pocan
    </lastName>
    <party>
     D
    </party>
    <state>
     WI
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000298
    </bioguideId>
    <fullName>
     Rep. Jayapal, Pramila [D-WA-7]
    </fullName>
    <firstName>
     Pramila
    </firstName>
    <lastName>
     Jayapal
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001068
    </bioguideId>
    <fullName>
     Rep. Cohen, Steve [D-TN-9]
    </fullName>
    <firstName>
     Steve
    </firstName>
    <lastName>
     Cohen
    </lastName>
    <party>
     D
    </party>
    <state>
     TN
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000216
    </bioguideId>
    <fullName>
     Rep. DeLauro, Rosa L. [D-CT-3]
    </fullName>
    <firstName>
     ROSA
    </firstName>
    <lastName>
     DELAURO
    </lastName>
    <party>
     D
    </party>
    <state>
     CT
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000481
    </bioguideId>
    <fullName>
     Rep. Tlaib, Rashida [D-MI-13]
    </fullName>
    <firstName>
     Rashida
    </firstName>
    <lastName>
     Tlaib
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000797
    </bioguideId>
    <fullName>
     Rep. Wasserman Schultz, Debbie [D-FL-23]
    </fullName>
    <firstName>
     Debbie
    </firstName>
    <lastName>
     Wasserman Schultz
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <district>
     23
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000191
    </bioguideId>
    <fullName>
     Rep. Neguse, Joe [D-CO-2]
    </fullName>
    <firstName>
     Joe
    </firstName>
    <lastName>
     Neguse
    </lastName>
    <party>
     D
    </party>
    <state>
     CO
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     O000173
    </bioguideId>
    <fullName>
     Rep. Omar, Ilhan [D-MN-5]
    </fullName>
    <firstName>
     Ilhan
    </firstName>
    <lastName>
     Omar
    </lastName>
    <party>
     D
    </party>
    <state>
     MN
    </state>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001145
    </bioguideId>
    <fullName>
     Rep. Schakowsky, Janice D. [D-IL-9]
    </fullName>
    <firstName>
     JANICE
    </firstName>
    <lastName>
     SCHAKOWSKY
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000191
    </bioguideId>
    <fullName>
     Rep. DeFazio, Peter A. [D-OR-4]
    </fullName>
    <firstName>
     PETER
    </firstName>
    <lastName>
     DEFAZIO
    </lastName>
    <party>
     D
    </party>
    <state>
     OR
    </state>
    <middleName>
     A.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000623
    </bioguideId>
    <fullName>
     Rep. DeSaulnier, Mark [D-CA-11]
    </fullName>
    <firstName>
     Mark
    </firstName>
    <lastName>
     DeSaulnier
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     11
    </district>
    <sponsorshipDate>
     2021-04-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000551
    </bioguideId>
    <fullName>
     Rep. Grijalva, Raúl M. [D-AZ-3]
    </fullName>
    <firstName>
     Raúl
    </firstName>
    <lastName>
     Grijalva
    </lastName>
    <party>
     D
    </party>
    <state>
     AZ
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-04-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000394
    </bioguideId>
    <fullName>
     Rep. Kim, Andy [D-NJ-3]
    </fullName>
    <firstName>
     Andy
    </firstName>
    <lastName>
     Kim
    </lastName>
    <party>
     D
    </party>
    <state>
     NJ
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-04-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000187
    </bioguideId>
    <fullName>
     Rep. Waters, Maxine [D-CA-43]
    </fullName>
    <firstName>
     MAXINE
    </firstName>
    <lastName>
     WATERS
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     43
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000586
    </bioguideId>
    <fullName>
     Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
    </fullName>
    <firstName>
     Jesus
    </firstName>
    <lastName>
     Garcia
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <middleName>
     G.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001278
    </bioguideId>
    <fullName>
     Rep. Bonamici, Suzanne [D-OR-1]
    </fullName>
    <firstName>
     Suzanne
    </firstName>
    <lastName>
     Bonamici
    </lastName>
    <party>
     D
    </party>
    <state>
     OR
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     L000592
    </bioguideId>
    <fullName>
     Rep. Levin, Andy [D-MI-9]
    </fullName>
    <firstName>
     Andy
    </firstName>
    <lastName>
     Levin
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000306
    </bioguideId>
    <fullName>
     Rep. Jones, Mondaire [D-NY-17]
    </fullName>
    <firstName>
     Mondaire
    </firstName>
    <lastName>
     Jones
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     L000581
    </bioguideId>
    <fullName>
     Rep. Lawrence, Brenda L. [D-MI-14]
    </fullName>
    <firstName>
     Brenda
    </firstName>
    <lastName>
     Lawrence
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <middleName>
     L.
    </middleName>
    <district>
     14
    </district>
    <sponsorshipDate>
     2021-06-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     Y000062
    </bioguideId>
    <fullName>
     Rep. Yarmuth, John A. [D-KY-3]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Yarmuth
    </lastName>
    <party>
     D
    </party>
    <state>
     KY
    </state>
    <middleName>
     A.
    </middleName>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-06-30
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000587
    </bioguideId>
    <fullName>
     Rep. Garcia, Sylvia R. [D-TX-29]
    </fullName>
    <firstName>
     Sylvia
    </firstName>
    <lastName>
     Garcia
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <middleName>
     R.
    </middleName>
    <district>
     29
    </district>
    <sponsorshipDate>
     2021-08-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Medicaid
     </name>
    </item>
    <item>
     <name>
      Medicare
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Public contracts and procurement
     </name>
    </item>
    <item>
     <name>
      Retail and wholesale trades
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-03-23
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-07-19T22:00:32Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Medicare Drug Price Negotiation Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs).&lt;/p&gt; &lt;p&gt;Under current law, the Centers for Medicare &amp;amp; Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS to (1) negotiate the prices of covered drugs; and (2) either establish a formulary for covered drugs, or require changes to PDP formularies that take into account CMS negotiations.&lt;/p&gt; &lt;p&gt; If the CMS is unable to negotiate an appropriate price for a drug in accordance with certain criteria, the price must be the lowest of three specified options (e.g., the median price in other countries). The CMS must identify drugs that are subject to negotiation, with priority given to certain categories of drugs based on usage and cost.&lt;/p&gt; &lt;p&gt;Additionally, drug manufacturers must issue rebates to the CMS for drugs dispensed to eligible low-income individuals. Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Medicare Drug Price Negotiation Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Medicare Drug Price Negotiation Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Medicare Drug Price Negotiation Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-03-23T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2139ih/xml/BILLS-117hr2139ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-03-24
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-03-24
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
2021-03-23
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-23
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-03-23
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
2021-03-23T15:06:30Z
Referred to
House
Energy and Commerce Committee
2021-03-24T15:21:53Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-03-23T15:06:35Z
Referred to
House
Ways and Means Committee
2021-03-23T16:39:53Z
Referred to
Health Subcommittee
hswm02
hswm00
Standing
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-03-23
VT
B001224
1
Cori
Rep. Bush, Cori [D-MO-1]
Bush
D
2021-03-23
MO
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-03-23
CA
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-03-23
WI
J000298
7
Pramila
Rep. Jayapal, Pramila [D-WA-7]
Jayapal
D
2021-03-23
WA
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2021-03-23
TN
D000216
3
ROSA
Rep. DeLauro, Rosa L. [D-CT-3]
DELAURO
D
2021-03-23
CT
T000481
13
Rashida
Rep. Tlaib, Rashida [D-MI-13]
Tlaib
D
2021-03-23
MI
W000797
23
Debbie
Rep. Wasserman Schultz, Debbie [D-FL-23]
Wasserman Schultz
D
2021-03-23
FL
N000191
2
Joe
Rep. Neguse, Joe [D-CO-2]
Neguse
D
2021-03-23
CO
O000173
5
Ilhan
Rep. Omar, Ilhan [D-MN-5]
Omar
D
2021-03-23
MN
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
SCHAKOWSKY
D.
D
2021-03-23
IL
D000191
4
PETER
Rep. DeFazio, Peter A. [D-OR-4]
DEFAZIO
A.
D
2021-03-23
OR
D000623
11
Mark
Rep. DeSaulnier, Mark [D-CA-11]
DeSaulnier
D
2021-04-14
CA
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-04-14
AZ
K000394
3
Andy
Rep. Kim, Andy [D-NJ-3]
Kim
D
2021-04-14
NJ
W000187
43
MAXINE
Rep. Waters, Maxine [D-CA-43]
WATERS
D
2021-06-16
CA
G000586
4
Jesus
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
Garcia
G.
D
2021-06-16
IL
B001278
1
Suzanne
Rep. Bonamici, Suzanne [D-OR-1]
Bonamici
D
2021-06-16
OR
L000592
9
Andy
Rep. Levin, Andy [D-MI-9]
Levin
D
2021-06-16
MI
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2021-06-16
NY
L000581
14
Brenda
Rep. Lawrence, Brenda L. [D-MI-14]
Lawrence
L.
D
2021-06-23
MI
Y000062
3
John
Rep. Yarmuth, John A. [D-KY-3]
Yarmuth
A.
D
2021-06-30
KY
G000587
29
Sylvia
Rep. Garcia, Sylvia R. [D-TX-29]
Garcia
R.
D
2021-08-24
TX
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-03-23
2021-03-24
Referred to the Subcommittee on Health.
House
Health
2021-03-23
Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
CRS
Identical bill
Medicare Drug Price Negotiation Act
S
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
N
DOGGETT
D
TX
Congressional oversight Government information and archives Government studies and investigations Health care costs and insurance Inflation and prices Medicaid Medicare Prescription drugs Public contracts and procurement Retail and wholesale trades
2021-03-23
Introduced in House
 <p><b>Medicare Drug Price Negotiation Act</b></p> <p>This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs).</p> <p>Under current law, the Centers for Medicare &amp; Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS to (1) negotiate the prices of covered drugs; and (2) either establish a formulary for covered drugs, or require changes to PDP formularies that take into account CMS negotiations.</p> <p> If the CMS is unable to negotiate an appropriate price for a drug in accordance with certain criteria, the price must be the lowest of three specified options (e.g., the median price in other countries). The CMS must identify drugs that are subject to negotiation, with priority given to certain categories of drugs based on usage and cost.</p> <p>Additionally, drug manufacturers must issue rebates to the CMS for drugs dispensed to eligible low-income individuals. Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.</p>
2021-07-19T22:00:32Z
00
2021-03-23T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2139ih/xml/BILLS-117hr2139ih.xml
Medicare Drug Price Negotiation Act
Medicare Drug Price Negotiation Act
Display Title
IH
Introduced in House
To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Medicare Drug Price Negotiation Act
Short Title(s) as Introduced
HR
2023-01-11T13:48:04Z
2023-01-11T13:48:04Z
3.0.0
2021-03-23
Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
CRS
Identical bill
Medicare Drug Price Negotiation Act
S
2021-03-24
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
2021-03-23
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-23
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-03-23
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
N
DOGGETT
D
TX
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-03-23
VT
B001224
1
Cori
Rep. Bush, Cori [D-MO-1]
Bush
D
2021-03-23
MO
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-03-23
CA
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-03-23
WI
J000298
7
Pramila
Rep. Jayapal, Pramila [D-WA-7]
Jayapal
D
2021-03-23
WA
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2021-03-23
TN
D000216
3
ROSA
Rep. DeLauro, Rosa L. [D-CT-3]
DELAURO
D
2021-03-23
CT
T000481
13
Rashida
Rep. Tlaib, Rashida [D-MI-13]
Tlaib
D
2021-03-23
MI
W000797
23
Debbie
Rep. Wasserman Schultz, Debbie [D-FL-23]
Wasserman Schultz
D
2021-03-23
FL
N000191
2
Joe
Rep. Neguse, Joe [D-CO-2]
Neguse
D
2021-03-23
CO
O000173
5
Ilhan
Rep. Omar, Ilhan [D-MN-5]
Omar
D
2021-03-23
MN
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
SCHAKOWSKY
D.
D
2021-03-23
IL
D000191
4
PETER
Rep. DeFazio, Peter A. [D-OR-4]
DEFAZIO
A.
D
2021-03-23
OR
D000623
11
Mark
Rep. DeSaulnier, Mark [D-CA-11]
DeSaulnier
D
2021-04-14
CA
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-04-14
AZ
K000394
3
Andy
Rep. Kim, Andy [D-NJ-3]
Kim
D
2021-04-14
NJ
W000187
43
MAXINE
Rep. Waters, Maxine [D-CA-43]
WATERS
D
2021-06-16
CA
G000586
4
Jesus
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
Garcia
G.
D
2021-06-16
IL
B001278
1
Suzanne
Rep. Bonamici, Suzanne [D-OR-1]
Bonamici
D
2021-06-16
OR
L000592
9
Andy
Rep. Levin, Andy [D-MI-9]
Levin
D
2021-06-16
MI
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2021-06-16
NY
L000581
14
Brenda
Rep. Lawrence, Brenda L. [D-MI-14]
Lawrence
L.
D
2021-06-23
MI
Y000062
3
John
Rep. Yarmuth, John A. [D-KY-3]
Yarmuth
A.
D
2021-06-30
KY
G000587
29
Sylvia
Rep. Garcia, Sylvia R. [D-TX-29]
Garcia
R.
D
2021-08-24
TX
Congressional oversight Government information and archives Government studies and investigations Health care costs and insurance Inflation and prices Medicaid Medicare Prescription drugs Public contracts and procurement Retail and wholesale trades
2021-03-23
Introduced in House
 <p><b>Medicare Drug Price Negotiation Act</b></p> <p>This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs).</p> <p>Under current law, the Centers for Medicare &amp; Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS to (1) negotiate the prices of covered drugs; and (2) either establish a formulary for covered drugs, or require changes to PDP formularies that take into account CMS negotiations.</p> <p> If the CMS is unable to negotiate an appropriate price for a drug in accordance with certain criteria, the price must be the lowest of three specified options (e.g., the median price in other countries). The CMS must identify drugs that are subject to negotiation, with priority given to certain categories of drugs based on usage and cost.</p> <p>Additionally, drug manufacturers must issue rebates to the CMS for drugs dispensed to eligible low-income individuals. Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.</p>
2021-07-19T22:00:32Z
00
Medicare Drug Price Negotiation Act
Medicare Drug Price Negotiation Act
Display Title
IH
Introduced in House
To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Medicare Drug Price Negotiation Act
Short Title(s) as Introduced
2021-03-24
Referred to the Subcommittee on Health.